Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Prodrug formulated to deliver simvastatin to skeletal tissue

Oct. 26, 2012

SJT Molecular Research divulges new agents for metabolic syndrome

Oct. 26, 2012

Phase III trial of reparixin in pancreatic islet transplantation enrolls first patient

Oct. 25, 2012

Compound-loaded artificial bone acts on host cells to induce regeneration

Oct. 25, 2012

Lilly reports results from three phase III AWARD trials

Oct. 24, 2012

Amicus achieves target enrollment in phase III migalastat hydrochloride study

Oct. 24, 2012

Alnylam and Genzyme form RNAi therapeutics alliance in Asia

Oct. 23, 2012

CHMP recommends approval of Krystexxa

Oct. 23, 2012

Recent clinical data support approval of canagliflozin

Oct. 23, 2012

Tresiba and Ryzodeg receive positive CHMP opinions

Oct. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...